Decipher Score predicts prostate specific antigen persistence after prostatectomy
Patrick‐Julien Treacy(Mount Sinai Hospital), Ash Tewari(Royal Free London NHS Foundation Trust), Ugo Giovanni Falagario(Ospedali Riuniti di Foggia), Ethan Wajswol(Icahn School of Medicine at Mount Sinai), Imad Bentellis(Université Côte d'Azur), Flora Barthe(Université Côte d'Azur), Alberto Martini(The University of Texas MD Anderson Cancer Center), Ivan Jambor(University of Turku), Parita Ratnani(Mount Sinai Hospital), Daniel Steffens(The University of Sydney), Scott Leslie(Royal Prince Alfred Hospital), Ruban Thanigasalam(Royal Prince Alfred Hospital), Sascha Karunaratne(Royal Prince Alfred Hospital), François MAGNIEZ(Icahn School of Medicine at Mount Sinai), M. Durand, Natasha Kyprianou(Icahn School of Medicine at Mount Sinai), Peter Wiklund(Unknown)
Cited by 4
Related Papers
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 Guidelines
|European Urology|2023|656
Tubulin-Targeting Chemotherapy Impairs Androgen Receptor Activity in Prostate Cancer
|Cancer Research|2010|350
Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease
|Annals of the Rheumatic Diseases|2001|287